The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Suberoylanilide Hydroxamic Acid Reactivates HIV from Latently Infected Cells
Open accessAbstract
Human immunodeficiency virus (HIV) persists in a latent form in infected individuals treated effectively with highly active antiretroviral therapy (HAART). In part, these latent proviruses account for the rebound in viral replication observed after treatment interruption. A major therapeutic challenge is to purge this reservoir. In this study, we demonstrate that suberoylanilide hydroxamic acid (SAHA) reactivates HIV from latency in chronically infected cell lines and primary cells. Indeed, P-TEFb, a critical transcription cofactor for HIV, is released and then recruited to the viral promoter upon stimulation with SAHA. The phosphatidylinositol 3-kinase/Akt pathway is involved in the initiation of these events. Using flow cytometry-based single cell analysis of protein phosphorylation, we demonstrate that SAHA activates this pathway in several subpopulations of T cells, including memory T cells that are the major viral reservoir in peripheral blood. Importantly, SAHA activates HIV replication in peripheral blood mononuclear cells from individuals treated effectively with HAART. Thus SAHA, which is a Food and Drug Administration-approved drug, might be considered to accelerate the decay of the latent reservoir in HAART-treated infected humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Minucci, S., & Pelicci, P. G. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1779 · Cited by 2,200
Finzi, D., Blankson, J., Siliciano, J. D., Margolick, J. B., Chadwick, K., Pierson, T., Smith, K., Lisziewicz, J., Lori, F., Flexner, C., et al. (1999) · Nature Medicine · doi:10.1038/8394 · Cited by 2,119
Controlling the elongation phase of transcription with P-TEFb
Peterlin, B. M., & Price, D. H. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.06.014 · Cited by 1,144
Self-citationDuvic, M., Talpur, R., Ni, X., Zhang, C., Hazarika, P., Kelly, C., Chiao, J. H., Reilly, J. F., Ricker, J. L., Richon, V. M., et al. (2007) · Blood · doi:10.1182/blood-2006-06-025999 · Cited by 1,141
Recruitment of P-TEFb for Stimulation of Transcriptional Elongation by the Bromodomain Protein Brd4
Yang, Z., Yik, J. H. N., Chen, R., He, N., Jang, M. K., Ozato, K., & Zhou, Q. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.029 · Cited by 1,138
Cytokine-Induced Expression of HIV-1 in a Chronically Infected Promonocyte Cell Line
Folks, T. M., Justement, J., Kinter, A., Dinarello, C. A., & Fauci, A. S. (1987) · Science · doi:10.1126/science.3313729 · Cited by 905
In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency
Chun, T.-W., Finzi, D., Margolick, J., Chadwick, K., Schwartz, D., & Siliciano, R. F. (1995) · Nature Medicine · doi:10.1038/nm1295-1284 · Cited by 787
7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes
Nguyen, V. T., Kiss, T., Michels, A. A., & Bensaude, O. (2001) · Nature · doi:10.1038/35104581 · Cited by 705
Nissen, R. M., & Yamamoto, K. R. (2000) · Genes & Development · doi:10.1101/gad.827900 · Cited by 559
Clouse, K. A., Powell, D., Washington, I., Poli, G., Strebel, K., Farrar, W., Barstad, P., Kovacs, J., Fauci, A. S., & Folks, T. M. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.2.431 · Cited by 542
Depletion of latent HIV-1 infection in vivo: a proof-of-concept study
Lehrman, G., Hogue, I. B., Palmer, S., Jennings, C., Spina, C. A., Wiegand, A., Landay, A. L., Coombs, R. W., Richman, D. D., Mellors, J. W., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67098-5 · Cited by 510
Jeronimo, C., Forget, D., Bouchard, A., Li, Q., Chua, G., Poitras, C., Thérien, C., Bergeron, D., Bourassa, S., Greenblatt, J., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.06.027 · Cited by 443
NF‐κB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation
Williams, S. A., Chen, L., Kwon, H., Ruiz‐Jarabo, C. M., Verdin, E., & Greene, W. C. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600900 · Cited by 430
Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.
Richon, V. M., Webb, Y., Merger, R., Sheppard, T., Jursic, B., Ngo, L., Civoli, F., Breslow, R., Rifkind, R. A., & Marks, P. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5705 · Cited by 420
Chun, T.-W., Engel, D., Mizell, S. B., Hallahan, C. W., Fischette, M., Park, S., Davey, R. T., Dybul, M., Kovacs, J. A., Metcalf, J. A., et al. (1999) · Nature Medicine · doi:10.1038/9498 · Cited by 404
Kulkosky, J., Culnan, D. M., Roman, J., Dornadula, G., Schnell, M., Boyd, M. R., & Pomerantz, R. J. (2001) · Blood · doi:10.1182/blood.v98.10.3006 · Cited by 329
Prostratin Antagonizes HIV Latency by Activating NF-κB
Williams, S. A., Chen, L.-F., Kwon, H., Fenard, D., Bisgrove, D., Verdin, E., & Greene, W. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402124200 · Cited by 318
Wang, F.-X., Xu, Y., Sullivan, J., Souder, E., Argyris, E. G., Acheampong, E. A., Fisher, J., Sierra, M., Thomson, M. M., Najera, R., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522574 · Cited by 252
Transcriptional Interference Antagonizes Proviral Gene Expression to Promote HIV Latency
Lenasi, T., Contreras, X., & Peterlin, B. M. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.05.016 · Cited by 245
Self-citationKrueger, B. J., Jeronimo, C., Roy, B. B., Bouchard, A., Barrandon, C., Byers, S. A., Searcey, C. E., Cooper, J. J., Bensaude, O., Cohen, E. A., et al. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn061 · Cited by 244
The multifactorial nature of HIV-1 latency
Lassen, K., Han, Y., Zhou, Y., Siliciano, J., & Siliciano, R. F. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.09.006 · Cited by 235
The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes
Ganesh, L., Burstein, E., Guha-Niyogi, A., Louder, M. K., Mascola, J. R., Klomp, L. W. J., Wijmenga, C., Duckett, C. S., & Nabel, G. J. (2003) · Nature · doi:10.1038/nature02171 · Cited by 226
Li, Q., Price, J. P., Byers, S. A., Cheng, D., Peng, J., & Price, D. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502712200 · Cited by 214
Effects of Prostratin on T-Cell Activation and Human Immunodeficiency Virus Latency
Korin, Y. D., Brooks, D. G., Brown, S., Korotzer, A., & Zack, J. A. (2002) · Journal of Virology · doi:10.1128/jvi.76.16.8118-8123.2002 · Cited by 208
HMBA Releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and Activates HIV Transcription
Contreras, X., Barboric, M., Lenasi, T., & Peterlin, B. M. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030146 · Cited by 206
Self-citationRamalingam, S. S., Parise, R. A., Ramananthan, R. K., Lagattuta, T. F., Musguire, L. A., Stoller, R. G., Potter, D. M., Argiris, A. E., Zwiebel, J. A., Egorin, M. J., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0162 · Cited by 193
Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription
Barboric, M., Yik, J. H. N., Czudnochowski, N., Yang, Z., Chen, R., Contreras, X., Geyer, M., Matija Peterlin, B., & Zhou, Q. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm063 · Cited by 189
Self-citationScripture-Adams, D. D., Brooks, D. G., Korin, Y. D., & Zack, J. A. (2002) · Journal of Virology · doi:10.1128/jvi.76.24.13077-13082.2002 · Cited by 183
Fantin, V. R., Loboda, A., Paweletz, C. P., Hendrickson, R. C., Pierce, J. W., Roth, J. A., Li, L., Gooden, F., Korenchuk, S., Hou, X. S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6091 · Cited by 170
Chen, R., Liu, M., Li, H., Xue, Y., Ramey, W. N., He, N., Ai, N., Luo, H., Zhu, Y., Zhou, N., et al. (2008) · Genes & Development · doi:10.1101/gad.1636008 · Cited by 163
Latency: the hidden HIV-1 challenge
Marcello, A. (2006) · Retrovirology · doi:10.1186/1742-4690-3-7 · Cited by 149
Inactivation of the HIV LTR by DNA CpG methylation: evidence for a role in latency.
Bednarik, D. P., Cook, J. A., & Pitha, P. M. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08222.x · Cited by 149
Andreeff, M., Stone, R. M., Michaeli, J., Cw, Y., Tong, W., Sogoloff, H., Ervin, T. J., Kufe, D. W., Rifkind, R. A., & Marks, P. (1992) · Blood · doi:10.1182/blood.v80.10.2604.2604 · Cited by 124
Pérez, V., Rowe, T., Justement, J. S., et al. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.9.3145 · Cited by 124
Stellbrink, H., van Lunzen, J., Westby, M., O’Sullivan, E., Schneider, C. G., Adam, A., Weitner, L., Kuhlmann, B., Hoffmann, C., Fenske, S., et al. (2002) · AIDS · doi:10.1097/00002030-200207260-00004 · Cited by 123
Decay dynamics of HIV-1 depend on the inhibited stages of the viral life cycle
Sedaghat, A. R., Dinoso, J. B., Shen, L., Wilke, C. O., & Siliciano, R. F. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711372105 · Cited by 120
Countryman, J. K., Gradoville, L., & Miller, G. (2008) · Journal of Virology · doi:10.1128/jvi.00116-08 · Cited by 112
Rahmani, M., Yu, C., Reese, E., Ahmed, W. B., Hirsch, K. G., Dent, P., & Grant, S. (2003) · Oncogene · doi:10.1038/sj.onc.1206646 · Cited by 107
Cassé, C., Giannoni, F., Nguyen, V. T., Dubois, M., & Bensaude, O. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.16097 · Cited by 105
He, N., Pezda, A. C., & Zhou, Q. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00778-06 · Cited by 100
Yik, J. H. N., Chen, R., Pezda, A. C., & Zhou, Q. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500912200 · Cited by 99
Li, N., Zhao, D., Kirschbaum, M. H., Zhang, C., Lin, C.-L. V., Todorov, I., KANDEEL, F. R., Forman, S. J., & Zeng, D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712051105 · Cited by 94
Ishida, T., Hamano, A., Koiwa, T., & Watanabe, T. (2006) · Retrovirology · doi:10.1186/1742-4690-3-69 · Cited by 87
Liu, Y., Denlinger, C. E., Rundall, B. K., Smith, P. W., & Jones, D. R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604478200 · Cited by 84
Hexamethylbisacetamide and Disruption of Human Immunodeficiency Virus Type 1 Latency in CD4+T Cells
Choudhary, S. K., Archin, N. M., & Margolis, D. M. (2008) · The Journal of Infectious Diseases · doi:10.1086/529525 · Cited by 73
NF-κ B-Dependent and -Independent Pathways of HIV Activation in a Chronically Infected T Cell Line
Antoni, B. A., Rabson, A. B., Kinter, A. L., et al. (1994) · Virology · doi:10.1006/viro.1994.1390 · Cited by 67
Siegel, D. S. D., Zhang, X., Feinman, R., Teitz, T., Zelenetz, A. D., Richon, V. M., Rifkind, R. A., Marks, P. A., & Michaeli, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.162 · Cited by 59
EBV EBNA 2 stimulates CDK9-dependent transcription and RNA polymerase II phosphorylation on serine 5
Bark-Jones, S. J., Webb, H., & West, M. J. (2005) · Oncogene · doi:10.1038/sj.onc.1209205 · Cited by 56
HIV-Induced Changes in T Cell Signaling Pathways
Schweneker, M., Favre, D., Martin, J. N., Deeks, S. G., & McCune, J. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.10.6490 · Cited by 47
Self-citationIL-7 as a potential therapy for HIV-1-infected individuals
Nunnari, G., & Pomerantz, R. J. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.11.1421 · Cited by 42
Klichko, V. I., Archin, N. M., Kaur, R., Lehrman, G. K., & Margolis, D. M. (2006) · Journal of Virology · doi:10.1128/jvi.80.9.4570-4579.2006 · Cited by 42
Vlach, J., & Pitha, P. M. (1993) · Journal of General Virology · doi:10.1099/0022-1317-74-11-2401 · Cited by 32
HIV Latency: Present Knowledge and Future Directions
Contreras, X., Lenasi, T., & Peterlin, B. M. (2006) · Future Virology · doi:10.2217/17460794.1.6.733 · Cited by 16
Self-citation
Cited by
Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure
Ho, Y.-C., Shan, L., Hosmane, N. N., Wang, J., Laskey, S. B., Rosenbloom, D. I. S., Lai, J., Blankson, J. N., Siliciano, J. D., & Siliciano, R. F. (2013) · Cell · doi:10.1016/j.cell.2013.09.020 · Cited by 1,405
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
Archin, N. M., Liberty, A. L., Kashuba, A. D., Choudhary, S. K., Kuruc, J. D., Crooks, A. M., Parker, D. C., Anderson, E. M., Kearney, M. F., Strain, M. C., et al. (2012) · Nature · doi:10.1038/nature11286 · Cited by 1,139
Shan, L., Deng, K., Shroff, N. S., Durand, C. M., Rabi, S. A., Yang, H.-C., Zhang, H., Margolick, J. B., Blankson, J. N., & Siliciano, R. F. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.014 · Cited by 714
Deeks, S. G. (2012) · Nature · doi:10.1038/487439a · Cited by 604
Self-citationComparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies
Eriksson, S., Graf, E. H., Dahl, V., Strain, M. C., Yukl, S. A., Lysenko, E. S., Bosch, R. J., Lai, J., Chioma, S., Emad, F., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003174 · Cited by 567
Self-citation
Metadata
- Authors
- Contreras, X., Schweneker, M., Chen, C.-S., McCune, J. M., Deeks, S. G., Martin, J., & Peterlin, B. M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2009-03
- Volume
- 284
- Issue
- 11
- Pages
- 6782-6789
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2125878780
- Cited by
- 277
- References
- 53
- FWCI
- 7.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.